This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Lipodystrophy
Information about Lipodystrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Lipodystrophy
Most recent studies have shown that Lipodystrophy shares some biological mechanisms with acquired-immunodeficiency-syndrome, acquired-partial-lipodystrophy, atrophy, cardiovascular-diseases, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, dyslipidemias, familial-generalized-lipodystrophy, familial-partial-lipodystrophy, hiv-associated-lipodystrophy-syndrome, hiv-infections, hyperlipidemia, hypertrophy, immunologic-deficiency-syndromes, insulin-resistance, insulin-sensitivity, obesity, whipple-disease.
Among the many pathways, these few ones have gauged particular interests from scientists studying Lipodystrophy, and have been seen in publications frequently: Adipose Tissue Development, Aging, Cell Cycle, Cell Death, Complement Activation, Energy Homeostasis, Fatty Acid Oxidation, Gluconeogenesis, Glucose Homeostasis, Glucose Transport, Hypersensitivity, Insulin Secretion, Lipid Homeostasis, Lipid Oxidation, Localization, Pathogenesis, Secretion, Tissue Development, Transport, Viral Replication
Quite a number of genes have been found to play important roles in Lipodystrophy, such as ADIPOQ, AGPAT2, BSCL2, C3, CD4, EMD, GHRH, IGF1, IL6, INS, INSR, LEP, LMNA, LPIN1, PPARG, SREBF1, TNF, ZMPSTE24. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.